Blockers of NO opened a depolarizing leak current, suggesting that NO acts at rest to block this current.
In such schemes, NO acts as a reductant of nitrate ions, ammonium nitrate and nitric acid.
NO acts as a vasodilator counteracting the ensuing vasoconstriction caused by endothelin-1, adenosine, and angiotensin II [29, 30].
At low levels, NO acts as an antioxidant by scavenging ROS and can bind to iron to reduce redox cycling (Trachootham et al., 2008).
The activity of the compounds in the nano- and picomolar ranges further suggests that NO acts as a potent cue, consistent with previous reports.
NO acts as a key modulator in cardiovascular, immunological, neurological, and respiratory systems, and deficiencies in the production of NO or its inactivation has been associated with several pathologic conditions, ranging from hypertension to sexual dysfunction.
The ability to study Aplysia CPG neurons cultured in isolation [24] allowed us to examine some of the cellular mechanisms by which NO acts on B31/B32.
The finding that blocking guanylyl cyclase also depolarizes B31/B32 suggested that NO acts via guanylyl cyclase, as it does in many other systems.
There is evidence that NO acts both in the central nervous system via a cyclic GMP pathway and in the periphery on sensory neurons through unknown mechanisms.
Nitric oxide (NO) acts as signaling molecule in inflammation.
In the immune response, NO acts as a functional cellular signalling molecule.
